MetLife Investment Management’s Array Biopharma Inc ARRY Stock Holding History

MetLife Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-98,675	Closed	-$4.57M	–	2464
2019 Q2	$4.57M	Buy	98,675 +7,481	+8%	+$210K	0.05%	393
2019 Q1	$2.22M	Hold	91,194	–	–	0.02%	769
2018 Q4	$1.3M	Hold	91,194	–	–	0.02%	931
2018 Q3	$1.39M	Hold	91,194	–	–	0.01%	995
2018 Q2	$1.53M	Sell	91,194 -91,194	-50%	-$1.45M	0.02%	872
2018 Q1	$2.98M	Buy	182,388 +91,194	+100%	+$1.46M	0.04%	618
2017 Q4	$1.17M	Buy	+91,194	New	+$1.04M	0.01%	973

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

MetLife Investment Management's ARRY Position: Q3 2019 in Review

MetLife Investment Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 98,675 shares — an estimated $4.57M sold.

MetLife Investment Management first reported a position in ARRY in Q4 2017 and held it in 7 quarters. The position peaked at $4.57M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

MetLife Investment Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
MetLife Investment Management sold 98,675 Array Biopharma Inc shares in Q3 2019, an estimated $4.57M.
MetLife Investment Management first reported a position in Array Biopharma Inc in Q4 2017 and held it in 7 quarters.
MetLife Investment Management's Array Biopharma Inc position peaked at $4.57M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on MetLife Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.